摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester | 1157581-03-7

中文名称
——
中文别名
——
英文名称
3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester
英文别名
3-{4-[(1S)-3-oxocyclopentyl]phenyl}propanoic acid ethyl ester;ethyl 3-[4-[(1S)-3-oxocyclopentyl]phenyl]propanoate
3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester化学式
CAS
1157581-03-7
化学式
C16H20O3
mdl
——
分子量
260.333
InChiKey
LSMQBFOXKKIPPL-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester 在 sodium tetrahydroborate 作用下, 以 乙醇 为溶剂, 反应 1.0h, 生成
    参考文献:
    名称:
    [EN] NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES
    [FR] NOUVEAUX COMPOSÉS HYDROCARBONÉS CYCLIQUES POUR LE TRAITEMENT DE MALADIES
    摘要:
    公开号:
    WO2009065406A3
  • 作为产物:
    描述:
    2-环戊烯酮4-(2-乙氧羰基乙基)苯基硼酸 在 [Rh(S-BINAP)(nbd)]BF4 三乙胺 作用下, 以 1,4-二氧六环 为溶剂, 以85%的产率得到3-[4-((1S)-3-oxo-cydopentyl)-phenyl]-propionic acid ethyl ester
    参考文献:
    名称:
    CYCLOALKYLAMINE DERIVATIVE
    摘要:
    公开号:
    EP2341044B1
点击查看最新优质反应信息

文献信息

  • CYCLOALKYLAMINE DERIVATIVES
    申请人:Marumoto Shinji
    公开号:US20120295943A9
    公开(公告)日:2012-11-22
    Provided is a therapeutic agent for hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like, which has a CaSR activating (agonist) action. A compound represented by the following general formula (1): [wherein, Ar which is a partial structure in the general formula (1) represents a phenyl group or a naphthyl group; R 1a and R 1b are the same or different from each other, and represent a hydrogen atom, a halogeno group, or the like; R 2a and R 2b are the same or different from each other, and represent a hydrogen atom, a halogeno group, or the like; A represents a single bond, an oxygen atom, or the like; B represents a single bond, a C1-C4 alkanediyl group, or the like; Z represents a carboxyl group or a tetrazolyl group; and m represents an integer of 1 to 3] or a pharmacologically acceptable salt thereof.
    提供了一种治疗甲状旁腺功能亢进、肾性骨营养不良、高钙血症等疾病的治疗剂,具有CaSR激活(激动剂)作用。该化合物由以下通式(1)表示:[其中,通式(1)中的部分结构Ar表示苯基或萘基;R1a和R1b相同或不同,表示氢原子,卤素基团或类似物;R2a和R2b相同或不同,表示氢原子,卤素基团或类似物;A表示单键,氧原子或类似物;B表示单键,C1-C4烷二基基团或类似物;Z表示羧基或四唑基;m表示1至3的整数]或其药学上可接受的盐。
  • Cycloalkylamne derivatives
    申请人:Marumoto Shinji
    公开号:US09133140B2
    公开(公告)日:2015-09-15
    Provided is a therapeutic agent for hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like, which has a CaSR activating (agonist) action. A compound represented by the following general formula (1): [wherein, Ar which is a partial structure in the general formula (1) represents a phenyl group or a naphthyl group; R1a and R1b are the same or different from each other, and represent a hydrogen atom, a halogeno group, or the like; R2a and R2b are the same or different from each other, and represent a hydrogen atom, a halogeno group, or the like; A represents a single bond, an oxygen atom, or the like; B represents a single bond, a C1-C4 alkanediyl group, or the like; Z represents a carboxyl group or a tetrazolyl group; and m represents an integer of 1 to 3] or a pharmacologically acceptable salt thereof.
    提供了一种治疗甲状旁腺功能亢进症、肾性骨营养不良、高钙血症等疾病的治疗剂,其具有CaSR激活(激动剂)作用。化合物由以下通式(1)表示:[其中,通式(1)中的部分结构Ar表示苯基或萘基;R1a和R1b相同或不同,表示氢原子,卤素基或类似物;R2a和R2b相同或不同,表示氢原子,卤素基或类似物;A表示单键,氧原子或类似物;B表示单键,C1-C4烷二基基团或类似物;Z表示羧基或四唑基;m表示1到3的整数]或其药学上可接受的盐。
  • NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES
    申请人:Fensholdt Jef
    公开号:US20100317582A1
    公开(公告)日:2010-12-16
    The invention relates to novel cyclic hydrocarbon compounds and derivatives thereof, processes for the preparation thereof, to said compounds for use as a medicament, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases with said compounds, and to the use of said compounds in the manufacture of medicaments.
    本发明涉及新的环烃化合物及其衍生物,其制备方法,以及将这些化合物用作药物、治疗用化合物、包含这些化合物的药物组合物、使用这些化合物治疗疾病的方法,以及将这些化合物用于药物制造的用途。
  • US9133140B2
    申请人:——
    公开号:US9133140B2
    公开(公告)日:2015-09-15
  • US9487494B2
    申请人:——
    公开号:US9487494B2
    公开(公告)日:2016-11-08
查看更多